Background illustration for clinical trials search

Paid Clinical Trials Edmond

Discover 573 paid clinical trials in Edmond, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Characterizing the Genomic Landscape of Cancer in Native American Populations (NAT-Geno)

for
Prostate Cancer, Renal Cell Carcinoma (RCC)
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: Male

Age: 18 - 70+

Code: NCT06960798

Recruiting

Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy

for
Breast Cancer, Lymphoma
Location: Oklahoma City OK, Tulsa OK
Sponsor: University of Oklahoma

Sex: All

Age: 18 - 70+

Code: NCT05921253

Early Phase 1, Recruiting

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

for
Ovarian Cancer, Non-small Cell Lung Cancer
Location: Oklahoma City OK, Irving TX, Fort Worth TX,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06303505

Phase 1, Phase 2, Recruiting

QTX3034 in Patients With KRAS G12D Mutation

for
Solid Tumors
Location: Oklahoma City OK, Houston TX, San Antonio TX, Denver CO,
Sponsor: Quanta Therapeutics

Sex: All

Age: 18+

Code: NCT06227377

Phase 1, Recruiting

ALPINE: Maintenance Letrozole/Abemaciclib

for
Endometrial Cancer, Recurrent Endometrial Cancer, TP53
Location: Oklahoma City OK, Aurora CO, Boston MA, Weymouth MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06366347

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Oklahoma City OK, Dallas TX, Kansas City KS, Omaha NE,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06001788

Phase 1, Recruiting

A Phase 1/1b Study of IAM1363 in HER2 Cancers

for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Oklahoma City OK, Dallas TX, Kansas City MO, Austin TX,
Sponsor: Iambic Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT06253871

Phase 1, Recruiting

A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

for
KRAS G12C Mutation, KRAS G12S Mutation,
Location: Oklahoma City OK, San Antonio TX, Denver CO,
Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT06720987

Phase 1, Recruiting

Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

for
Infusion Reactions
Location: Oklahoma City OK, Dallas TX, Fort Worth TX, Omaha NE,
Sponsor: New York Blood Center

Sex: All

Age: 0+

Code: NCT01656603

Phase 2, Recruiting

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for
Neoplasms
Location: Oklahoma City OK, Wichita KS, Dallas TX, Westwood KS,
Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase 2, Phase 3, Recruiting

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

for
Endometrial Adenocarcinoma
Location: Oklahoma City OK, Kansas City MO, Little Rock AR,
Sponsor: Acrivon Therapeutics

Sex: Female

Age: 18+

Code: NCT05548296

Phase 2, Recruiting

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

for
Cervical Cancer
Location: Oklahoma City OK, Bedford TX, Dallas TX, Fort Worth TX,
Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT04831580

Recruiting

A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants

for
Pneumococcal Disease
Location: Oklahoma City OK, Plano TX, Shreveport LA, Lincoln NE,
Sponsor: Pfizer

Sex: All

Age: 0

Code: NCT07573462

Phase 3, Recruiting

Analgesic Comparison of PENG/LFCN to FICB for Total Hip Arthroplasty

for
Analgesia
Location: Oklahoma City OK
Sponsor: SSM Health Bone and Joint Hospital at St Anthony

Sex: All

Age: 40 - 70+

Code: NCT05477641

Recruiting

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

for
Non Small Cell Lung Cancer
Location: Oklahoma City OK, Springdale AR, Little Rock AR,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312137

Phase 3, Recruiting

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Oklahoma City OK, Dallas TX, Arlington TX, Tyler TX,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07213674

Phase 3, Recruiting

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

for
Peripheral Artery Disease (PAD)
Location: Oklahoma City OK, Plano TX, DeSoto TX, Amarillo TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07318610

Phase 3, Recruiting

Prospective Study to Assess a Diagnostic Aid for Cancer

for
Cancer
Location: Oklahoma City OK, Hutchinson KS, Kansas City MO,
Sponsor: Harbinger Health

Sex: All

Age: 45+

Code: NCT07046260

Recruiting

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

for
Cancer Weight Loss
Location: Oklahoma City OK, Wichita KS, Lincoln NE, Omaha NE,
Sponsor: Endevica Bio

Sex: All

Age: 18+

Code: NCT06937177

Phase 2, Recruiting

Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma

for
CRC Screening, CRC (Colorectal Cancer)
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 45 - 70+

Code: NCT07254910

Recruiting